Abstract

The contributions of asymptomatic infections to herd immunity and community transmission are key to the resurgence and control of COVID-19, but are difficult to estimate using current models that ignore changes in testing capacity. Using a model that incorporates daily testing information fit to the case and serology data from New York City, we show that the proportion of symptomatic cases is low, ranging from 13 to 18%, and that the reproductive number may be larger than often assumed. Asymptomatic infections contribute substantially to herd immunity, and to community transmission together with presymptomatic ones. If asymptomatic infections transmit at similar rates as symptomatic ones, the overall reproductive number across all classes is larger than often assumed, with estimates ranging from 3.2 to 4.4. If they transmit poorly, then symptomatic cases have a larger reproductive number ranging from 3.9 to 8.1. Even in this regime, presymptomatic and asymptomatic cases together comprise at least 50% of the force of infection at the outbreak peak. We find no regimes in which all infection subpopulations have reproductive numbers lower than three. These findings elucidate the uncertainty that current case and serology data cannot resolve, despite consideration of different model structures. They also emphasize how temporal data on testing can reduce and better define this uncertainty, as we move forward through longer surveillance and second epidemic waves. Complementary information is required to determine the transmissibility of asymptomatic cases, which we discuss. Regardless, current assumptions about the basic reproductive number of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) should be reconsidered.

Highlights

  • The contributions of asymptomatic infections to herd immunity and community transmission are key to the resurgence and control of COVID-19, but are difficult to estimate using current models that ignore changes in testing capacity

  • We show that most COVID19 infections are asymptomatic, and that these asymptomatic infections together with presymptomatic ones substantially drive community transmission, contributing 50% or more of the total force of infection

  • A key question to consider when evaluating the plausibility of this magnitude of undetected infections is whether it is consistent with no signal of an anomalous number of hospitalizations. Would this large rise in early infections result in a corresponding rise in COVID hospitalizations that may not have been detected as COVID related? We examine this question by comparing simulated daily hospitalizations from our fitted model with observed COVID-19 daily hospitalizations in New York City, as well as with syndrome surveillance reports of respiratory illness from emergency departments in New York City hospitals (Fig. 5), which we can use as an indicator for a rise in undetected hospitalizations

Read more

Summary

Introduction

The contributions of asymptomatic infections to herd immunity and community transmission are key to the resurgence and control of COVID-19, but are difficult to estimate using current models that ignore changes in testing capacity. Schools and universities in the United States are gradually reopening amid concerns that a second wave of the epidemic may reemerge in the fall and winter of 2020 As they craft testing policies and intervention strategies to mitigate a second wave, public health officials need to better understand the role that symptomatic and asymptomatic individuals play in the community transmission of COVID-19 and in the development of herd immunity to the disease. These questions are especially urgent given ambiguity in recent Centers for Disease Control and Prevention (CDC) guidelines regarding the testing of asymptomatic individuals [3] Answering these questions can provide further insight on the basic reproductive number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and how the virus would spread in a population in the absence of interventions. The probability that a COVID-19 infection is symptomatic is difficult to estimate [14], and a wide range of values have been

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.